Stock Events

NeuroBo Pharmaceuticals 

$5.35
26
-$0.38-6.7% Friday 20:50

Statistics

Day High
-
Day Low
-
52W High
7.6
52W Low
2.89
Volume
62,173
Avg. Volume
3,872,765
Mkt Cap
204.54M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

28MarExpected
Q1 2022
Q2 2022
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Next
-5.1
-3.41
-1.71
-0.02
Expected EPS
-0.12
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NRBO. It's not an investment recommendation.

About

Health Technology
Pharmaceuticals: Major
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative and cardiometabolic diseases. Its therapeutics programs include NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of protein; and Gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia. NeuroBo Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Boston, Massachusetts.
Show more...
CEO
Employees
7
Country
US
ISIN
US64132R1077

Listings